Skip to content

Extra Short Implants Brånemark System® RP Ø4.5x4.5 mm Implants

A 5-year Clinical Evaluation on Brånemark System® RP Ø4.5x4.5 mm Implants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02178891
Enrollment
144
Registered
2014-07-01
Start date
2010-01-31
Completion date
2019-08-31
Last updated
2014-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers With Severely Resorbed Jaws in Need of an Implant Supported Restoration

Keywords

short implants, Nobel Biocare, partially edentulous, maxilla or mandible

Brief summary

An extra short, 2-piece implant with a Brånemark hexagon interface was developed with a bone anchoring length of only 4.5 mm, for subjects with severely resorbed jaws.

Interventions

DEVICEextra short implant

Sponsors

Nobel Biocare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The subject should be at least 18 years of age and have passed secession of growth * The subject should be in need of an implant-supported restoration in the posterior region of the mouth (maxilla: first premolar to third molar, mandible: first premolar to second molar, not third molar due to mobile gingiva), where at least 2 implants are needed of which at least one should be an Extra Short Implant * Obtained informed consent from the subject * The subject must be in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems * The subject should have a severely resorbed posterior mandible and/ or maxilla. * Implants are only to be placed in healed sites, defined as a site with minimum 6 months of healing following tooth extraction * At least 6 mm residual bone width, between 4-7 mm residual bone height in the maxilla and between 6-9 mm residual bone height in the mandible * At implant installation the implant should be stable; final tightening torque of the implant about 25 Ncm or higher, preferably not exceeding 45 Ncm * The subject should be healthy and compliant with good oral hygiene * Favorable and stable occlusal relationship

Exclusion criteria

* The subject is not able to give her/his informed consent of participating * Health conditions, which do not permit the surgical treatment * Reason to believe that the treatment might have a negative effect on the subject's total situation (psychiatric problems), as noted in subject records or in subject history * Any disorders in the planned implant area such as previous tumours, chronic bone disease or previous irradiation * Alcohol or drug abuse as noted in subject records or in subject history. * Heavy smoking (\>10 cigarettes/day) * Intake of medication containing bisphosphonates * Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake * Severe bruxism or other destructive habits * Immediate insertion (i.e. placement of the implant immediately after extraction) * Bone augmentation procedures before or at implant installation is not allowed * Deviation from stated drilling protocol, utilizing osteotomes, is not allowed * Lack of opposing dentition * Single crown restorations are not to be performed in the study

Design outcomes

Primary

MeasureTime frame
marginal bone level changesyearly, up to 5 years

Secondary

MeasureTime frame
cumulative survival and success ratesyearly, up to 5 years

Other

MeasureTime frame
difference between maxilla and mandibleyearly, up to 5 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026